癌症后育龄女性生育治疗的使用情况
这项基于人群的队列研究通过详细访谈比较了1036名女性癌症幸存者与1026名无癌症史匹配女性在癌症后寻求不孕症诊治及接受生育治疗的情况。结果显示,幸存者就诊求助怀孕的可能性与无癌症史女性无显著差异(HR 1.16,95%模拟区间0.78-1.74),接受任何生育治疗、使用激素或药物、进行宫腔内人工授精的概率也相似,仅手术干预略高(HR 1.55,95%模拟区间0.67-3.71)。作者建议在治疗完成后对年轻成年女性癌症患者进行生育选择的咨询和教育。
要点
- 癌症幸存者就诊求助怀孕的可能性与无癌症史女性无显著差异(HR 1.16,95%模拟区间0.78-1.74)。
- 幸存者接受任何生育治疗的概率与无癌症史女性相似(aHR 0.88,95%模拟区间0.46-1.56)。
- 在就诊但拒绝生育治疗的女性中,四分之一报告因费用原因拒绝治疗。
核心结论
- 癌症幸存者使用生育治疗的比例并不高于一般人群。
- 作者建议在治疗完成后对年轻成年女性癌症患者进行生育选择的咨询和教育。
研究设计与样本
- 基于人群的队列研究,通过详细访谈收集生育史。
- 女性癌症幸存者1036名,年龄22-45岁,在20-35岁之间诊断为癌症且距诊断至少2年;年龄匹配的无癌症史对照女性1026名。
- 每位幸存者随机匹配一名对照女性,并赋予其与匹配幸存者相同的虚拟诊断年龄,匹配重复1000次。
- 采用Cox比例风险回归模型分析就诊求助怀孕或接受生育治疗的结果,调整种族、收入、居住地、教育程度和产次。
主要发现
- 仅25.5%的癌症幸存者在癌症诊断前达到其期望的家庭规模。
- 幸存者从诊断到访谈的中位时间为7年(四分位距5-11年)。
- 访谈时,癌症幸存者报告无子女的比例为32.6%,高于无癌症史女性的19.5%。
- 以出生年份匹配并按幸存者诊断年龄随访,幸存者就诊求助怀孕的可能性与无癌症史女性无显著差异(HR 1.16,95%模拟区间0.78-1.74)。
- 与无癌症女性相比,幸存者接受任何治疗(aHR 0.88,95%模拟区间0.46-1.56)、使用激素或药物(aHR 0.86,95%模拟区间0.46-1.63)或进行宫腔内人工授精(aHR 1.26,95%模拟区间0.40-5.88)的概率相似;接受手术干预的概率略高(HR 1.55,95%模拟区间0.67-3.71)。
临床怎么用
- 作者建议在治疗完成后对年轻成年女性癌症患者进行生育选择的咨询和教育。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether female cancer survivors are more likely to pursue care for infertility after cancer than women without cancer. DESIGN: Population-based cohort study involving detailed interviews regarding reproductive history. SETTING: Not applicable. PATIENTS: Female cancer survivors aged 22-45 years, who were at least 2 years after a cancer diagnosis between the ages of 20 and 35 years (n = 1,036), and age-matched comparison women with no cancer history (n = 1,026). EXPOSURE: History of cancer vs. no history of cancer. MAIN OUTCOME MEASURE(S): Each cancer survivor was randomly matched to a comparison woman, who was assigned an artificial age at cancer diagnosis equal to that of her match. Matching was repeated 1,000 times. Outcomes of visiting a doctor for help becoming pregnant or undergoing fertility treatment were modeled using Cox proportional hazards regression, comparing survivors after a cancer diagnosis to age-matched comparison women, adjusted for race, income, residence, education, and parity. RESULTS: Only 25.5% of cancer survivors reported meeting their desired family size before a cancer diagnosis. The median time from diagnosis to interview among survivors was 7 (interquartile range 5-11) years. Cancer survivors were more likely to report having no children (32.6%) at the interview compared with women with no cancer history (19.5%). Survivors were not more likely to visit a doctor for help becoming pregnant compared with women without a cancer history, matched on birth year and followed by the age at which cancer survivors received their diagnosis (hazard ratio [HR] 1.16, 95% simulation interval [SI] 0.78-1.74). Compared with cancer-free women, cancer survivors had similar probabilities of pursuing any treatment (adjusted HR [aHR] 0.88, 95% SI 0.46-1.56), using hormones or medications (aHR 0.86, 95% SI 0.46-1.63), or undergoing intrauterine insemination (aHR 1.26, 95% SI 0.40-5.88) to conceive. Cancer survivors were slightly more likely to pursue surgical interventions to become pregnant (HR 1.55, 95% SI 0.67-3.71). Of those who visited a doctor but declined to pursue fertility treatment, one-quarter of women reported declining treatment due to cost. CONCLUSION: Cancer survivors did not use fertility treatments at higher rates than the general population. Further counseling and education surrounding fertility options are recommended for young adult female cancer patients after treatment is completed.
引用
- Kipling LM, Shandley LM, Mertens AC, et al. The use of fertility treatments among reproductive-aged women after cancer. Fertil Steril. 2023. PMID: 38103881. doi:10.1016/j.fertnstert.2023.12.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。